← Back to Vaccine Database

mRNA-1273

RNA based vaccine · VDDBV0500

Target & Classification

SARS-CoV-2SARS-CoV-2
RNA based vaccine
COVID-19
ApprovedPhase 4 reached

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials47

Note: 3 additional source trials listed this vaccine in studies of unrelated viruses (e.g. as a comparator, adjunct, or in coadministration trials with other vaccines). Those trials are not shown here.

NCT IDPhaseDisease / Condition
NCT04283461 Phase 1COVID-19
NCT04839315 Phase 1COVID-19
NCT04677660 Phase 2COVID-19
NCT04712110 Phase 2COVID-19
NCT04889209 Phase 2COVID-19
NCT05280158 Phase 2COVID-19
NCT04405076 Phase 2COVID-19
NCT05315362 Phase 2COVID-19
NCT05289037 Phase 2COVID-19
NCT04761822 Phase 2COVID-19
NCT04894435 Phase 2COVID-19
NCT04930770 Phase 2COVID-19
NCT04969263 Phase 2COVID-19
NCT05077254 Phase 2COVID-19
NCT05137236 Phase 2COVID-19
NCT05137236 Phase 2COVID-19
NCT05197153 Phase 2COVID-19
NCT04649151 Phase 3COVID-19
NCT04796896 Phase 3COVID-19
NCT05022329 Phase 3COVID-19
NCT05168813 Phase 3COVID-19
NCT05236491 Phase 3COVID-19
NCT05249829 Phase 3COVID-19
NCT05279365 Phase 3COVID-19
NCT04470427 Phase 3COVID-19
NCT04811664 Phase 3COVID-19
NCT05299359 Phase 3COVID-19
NCT04805125 Phase 3COVID-19
NCT04806113 Phase 3COVID-19
NCT04860297 Phase 3COVID-19
NCT05048940 Phase 3COVID-19
NCT05119855 Phase 3COVID-19
NCT05142319 Phase 3COVID-19
NCT05158140 Phase 3COVID-19
NCT05230953 Phase 3COVID-19
NCT04760132 ApprovedCOVID-19
NCT05060991 ApprovedCOVID-19
NCT04792567 ApprovedCOVID-19
NCT04885907 ApprovedCOVID-19
NCT04952402 ApprovedCOVID-19
NCT04969250 ApprovedCOVID-19
NCT05030974 ApprovedCOVID-19
NCT05047718 ApprovedCOVID-19
NCT05079633 ApprovedCOVID-19
NCT05075538 ApprovedCOVID-19
NCT05075538 ApprovedCOVID-19
NCT05160766 ApprovedCOVID-19